Sort
261,768 grants matching “gene therapy”
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$2,070,386Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
$2,070,225Bridget F Grant · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Cellular and Molecular Mechanisms of Atherosclerosis
$2,070,048Alan Richard Tall · Columbia University Health Sciences · P01 · FY2024 · HL
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,069,846Roy S Herbst · Yale University · P50 · FY2023 · CA
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors
$2,069,712Siddarth Selvaraj · Arima Genomics, Inc. · R44 · FY2023 · CA
Identification of human genes of iron homeostasis
$2,069,637Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,069,565Steven Mark Albelda · University Of Pennsylvania · P01 · FY2019 · CA
Gene Therapy for Hemophilia
$2,069,413Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2012 · HL
Preclinical drug development in pancreatic cancer
$2,069,338Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SPORE in Brain Cancer
$2,069,263Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$2,069,205Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2025 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$2,069,205Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2024 · CA
Molecular Diagnostics Core Laboratory
$2,068,937Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
The Biology of HIV Infections
$2,068,853Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Antecedent Biomarkers For AD: The Adult Children Study
$2,068,818John Morris · Washington University · P01 · FY2020 · AG
BIOLOGY OF OVARIAN CANCER
$2,068,795University Of California San Francisco · P01 · FY2001 · CA
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,068,764Joseph Eric Levitt · Stanford University · UH3 · FY2022 · HL
Sarcoidosis and A1AT Genomics & Informatics Center
$2,068,387Naftali Kaminski · University Of Pittsburgh At Pittsburgh · U01 · FY2012 · HL
Drug Metabolizing Enzymes In Humans And Animal Models
$2,068,287Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Cardiac Fibrillation: Mechanisms and Therapy
$2,068,286University Of California Los Angeles · P01 · FY2005 · HL
Novel Approaches for the Control of Microbial Pathogens
$2,068,212Joseph F Lutkenhaus · University Of Kansas Medical Center · P20 · FY2008 · RR
Anatomic Pathology Residency Program
$2,067,992Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2023 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,067,796Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
Antecedent Biomarkers For AD: The Adult Children Study
$2,067,511John Morris · Washington University · P01 · FY2017 · AG
Gene Therapy for Sickle Cell Disease
$2,067,487St. Jude Children'S Research Hospital · P01 · FY2004 · HL